Class Action Lawsuit Blog
Italy’s First Ever Class Action Upheld
Class action lawsuits may become much more common in Italy after the first successful case was approved
Pradaxa: If it’s so bad, why do the U.S. and Europe still use it?
The anticoagulant drug Pradaxa has been linked to serious side effects including bleeding and strokes - so why is it still being used?
Australian Actos Victims Set To Join U.S. Class Action Lawsuit
Actos makers already facing legal action in the U.S. may soon face claims from Australian patients of the diabetes drug.
Force Placed Insurance Class Action Cases Get the Go-Ahead from Florida Judge
Force placed insurance cases against major banks and insurance providers are set to go forward after a judge denied dismissal.
Is Your Doctor Getting Paid By Big Pharma? Lawsuits Result in Online Database of Doctors on the Take
Whistleblower lawsuits and a new federal law require doctors to disclose the compensation they receive from pharmaceutical companies.
Johnson & Johnson Metal Hip Replacement To Be Pulled
J&J subsidiary DePuy is to cease selling and distributing two types of hip implants following hundreds of lawsuits were filed over related products.
They Don’t Already Have Them? Class Actions Coming to South Korea
As part of the country's economic democratization pledge, class action lawsuits are to be introduced to South Korea - along with all the benefits and problems they can bring.
Skechers Settles False Advertising Suit for $45 Million
Skechers has agreed to pay $40 million, plus $5 million in attorneys’ fees, to settle a class action lawsuit alleging that the company deceived its customers by making unsupported claims that its sneakers would help people lose weight and tone muscles.
Stryker Hip Implants Status Conference Update
The latest news and updates about the ongoing Stryker hip implant lawsuits.
Pradaxa MDL Litigation Update: Judge Orders Defendant to Hand Over Documents Used to Prepare Witness
The federal judge presiding over the Pradaxa multidistrict litigation ordered the maker of the drug to turn over documents that its lawyers used to prepare a witness for a deposition.